Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Predictive Biomarkers for Gemc...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Predictive Biomarkers for Gemcitabine as a Chemoradiosensitizer in Bladder Cancer
Bibliographic Details
Main Authors:
Kerr, M
,
Kiltie, A
Format:
Conference item
Published:
2012
Holdings
Description
Similar Items
Staff View
Similar Items
Gemcitabine as a Chemoradiosensitiser in Bladder Cancer
by: Kerr, M, et al.
Published: (2012)
A multicentre NCRI phase II study of hypofractionated conformal radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer
by: Choudhury, A, et al.
Published: (2010)
Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer.
by: Choudhury, A, et al.
Published: (2011)
Predictive biomarkers in muscle-invasive bladder cancer
by: Walker, A
Published: (2017)
Ultrasound mediated gemcitabine delivery reduces the normal tissue toxicity of chemoradiation therapy in a muscle-invasive bladder cancer model
by: Ruan, J-L, et al.
Published: (2021)